ATLAS

Alaunos Therapeutics (TCRT) Q3 2026 earnings results

Alaunos Therapeutics (TCRT) reported EPS of -$0.31 against an analyst estimate of -$2.05: a beat of $1.74 (84.9%). The quarter ended Sep 30, 2026; the company reported on Friday, November 20, 2026.

Status: Confirmed · 06:00 ET, Nov 20 · Source: EODHD (calendar and fundamentals, cross-checked)

Get an email before and after Alaunos Therapeutics reports, free with your ATLAS account

Earnings alerts are a free benefit of your ATLAS account. The company goes to your watchlist and we email you when it reports. Google signup is one click.

Create free account

TCRT Q3 2026 results at a glance

EPS reported-$0.31
EPS estimate-$2.05
SurpriseBeat · +$1.74 (+84.9%)
Quarter endedSep 30, 2026
ReportedNov 20, 2026
StatusConfirmed · 06:00 ET, Nov 20

EPS is as supplied by EODHD, in US dollars per share; whether it is adjusted or GAAP follows that source. This is Alaunos Therapeutics’s Q3 2026, a calendar-year company.

Alaunos Therapeutics EPS surprise history: last 3 quarters

Alaunos Therapeutics beat the EPS estimate in 3 of its last 3 reports, with an average surprise of +123.4%.

Report dateEPS est.EPS actualSurpriseResultMove*
Nov 20, 2026-$2.05-$0.31+84.9%Beat–
Jul 15, 2026$1.52$1.64+7.9%Beat-1.0%
Mar 25, 2026-$0.53$0.94+277.4%Beat-4.1%

*Move: change in the closing price from the last close before the report day to the close the day after it. It is filled in a few trading days after each report.

TCRT stock reaction to the report

The price reaction will be added after the Nov 23, 2026 close.

This section appears once a post-report closing price exists and updates with every new close.

Next TCRT earnings report

Alaunos Therapeutics has not announced its next earnings date yet. This page shows a date only once it is confirmed. See the TCRT earnings calendar.

ATLAS fair value and signal for TCRT

Last price$1.68 (+5.7%)
Chance of a higher close in 1 month39% (normal range $1.08–$2.01)

These are model outputs from the same valuation and calibrated model as the Alaunos Therapeutics stock page. They describe an ordinary period and are not a forecast of any particular outcome.

Alaunos Therapeutics Q3 2026 earnings: frequently asked questions

Did Alaunos Therapeutics beat earnings estimates for Q3 2026?

Alaunos Therapeutics reported EPS of -$0.31 against an analyst estimate of -$2.05: a beat of $1.74 (84.9%).

When did Alaunos Therapeutics report Q3 2026 results?

Alaunos Therapeutics reported on Friday, November 20, 2026, for the quarter ended Wednesday, September 30, 2026.

How often does TCRT beat EPS estimates?

In its last 3 reports with a recorded result, Alaunos Therapeutics beat the EPS estimate 3 times; the average surprise was +123.4%. Past results do not predict the next one.

How does ATLAS confirm a result?

A result is published only after it is cross-checked: the EODHD earnings calendar and the EODHD fundamentals feed must show the same EPS for the same fiscal period, or the same value must appear in two consecutive checks. Unconfirmed figures are never published. If the figures are revised later, this page updates.

Educational information, not investment advice. Disclaimer

ATLAS Signals

ATLAS Signals, every week

The week in the market, three stocks on ATLAS’s radar and what comes next. Get it every Monday.

By subscribing you agree to receive ATLAS Signals by email every Monday. You can unsubscribe with one click at any time. Privacy